Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave

Stefania Principe, Alida Benfante, Nicola Scichilone, Alida Benfante, Stefania Principe, Carmen Durante, Gabriele Seminara, Maria Noemi Cicero, Maria Incandela, Nicola Scichilone, Carmen Durante, Gabriele Seminara, Maria Incandela, Maria Noemi Cicero

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.
Original languageEnglish
Number of pages0
JournalPULMONARY PHARMACOLOGY & THERAPEUTICS
Publication statusPublished - 2022

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave'. Together they form a unique fingerprint.

Cite this